Gene therapy of the human retina reduction may lead to the development of AMD. In animal model, an AAV with human PEDF cDNA under the control of the CMV promoter prevented choroidal and retinal NV ( 24). The finding suggests that the AAV-mediated expression of angiostatic factors can be implemented to treat NV. This approach could be useful as an alternative to frequent injections of recombinant protein into the eye. In addition, PEDF and sFlt-1 may be able to diffuse through sclera tissue, allowing for the potential to be relatively independent of the intraocular site of administration. Gene therapy of the human retina Retinal gene therapy
Development of the human cerebral cortex Development of the human cerebral cortex Corticogenesis is the process in which the cortex of the brain is created during neurodevelopment. The cortex is the outer layer of the brain and is composed of up to six layers. Neurons formed in the ventricular zone migrate to their final locations in one of the six layers of the cortex The process occurs from embryonic day 10 to 17 in mice and between gestational weeks seven to 18 in humans. The preplate is the first stage in corticogenesis prior to the development of the cortical plate. The preplate is located between the